AXA NV25 (CSNV.PA) Stock Earnings & Estimates
Europe - EPA:CSNV - FR001400UEZ6 - Common Stock
40 EUR
+0.8 (+2.04%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 122.307B 7.79% | 105.176B -14.01% | 85.109B -19.08% | 95.541B 12.26% | 99.749B 4.40% | 100.258B 0.51% | N/A | N/A | |
| EBITDA YoY % growth | 10.779B 37.28% | N/A -12.21% | N/A 6.34% | 10.483B 4.17% | 11.056B 5.47% | 11.731B 6.11% | N/A | N/A | |
| EBIT YoY % growth | 9.909B 48.43% | 10.933B 10.33% | 9.491B -13.19% | 9.472B -0.20% | 10.005B 5.63% | 10.428B 4.23% | 12.226B 17.24% | 12.302B 0.62% | |
| Operating Margin | 8.10% | 10.39% | 11.15% | 9.91% | 10.03% | 10.40% | N/A | N/A | |
| EPS YoY % growth | 2.75 60.82% | 3.08 12.00% | N/A 10.30% | 3.62 6.50% | 3.93 8.63% | 4.53 15.27% | 4.53 -0.03% | 4.67 3.16% |
All data in EUR
| Q2 / 24 | |
|---|---|
| EPS Q2Q % growth | 1.80 0.70% |
| Revenue Q2Q % growth | 54.142B 32.57% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 15.24% | 1.65 | % | |
| Q2 2023 Q2Q % growth | 1.79 8.48% | 1.78 | 0.01 | 0.75% |
| Q4 2022 Q2Q % growth | 1.43 12.60% | 1.50 | -0.07 | -4.91% |
| Q2 2022 Q2Q % growth | 1.65 11.49% | 1.50 | 0.15 | 9.72% |
| Q4 2021 Q2Q % growth | 1.27 39.56% | 1.45 | -0.18 | -12.55% |
| Q2 2021 Q2Q % growth | 1.48 85.00% | 1.42 | 0.06 | 4.50% |
| Q4 2020 Q2Q % growth | 0.91 | 0.97 | -0.06 | -6.01% |
| Q2 2020 Q2Q % growth | 0.80 -50.92% | 0.69 | 0.11 | 15.93% |
| Q2 2019 Q2Q % growth | 1.63 | 1.54 | 0.09 | 5.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 44.27B -23.49% | 52.515B | -8.245B | -15.70% |
| Q2 2023 Q2Q % growth | 40.839B -4.76% | 57.537B | -16.698B | -29.02% |
| Q4 2022 Q2Q % growth | 57.861B -6.02% | 52.48B | 5.381B | 10.25% |
| Q2 2022 Q2Q % growth | 42.881B -29.90% | 55.225B | -12.344B | -22.35% |
| Q4 2021 Q2Q % growth | 61.569B 1.14% | 47.304B | 14.265B | 30.16% |
| Q2 2021 Q2Q % growth | 61.171B 16.59% | 35.662B | 25.509B | 71.53% |
| Q4 2020 Q2Q % growth | 60.876B 2.78% | % | ||
| Q2 2020 Q2Q % growth | 52.469B -29.77% | % | ||
| Q4 2019 Q2Q % growth | 59.229B | 42.144B | 17.085B | 40.54% |
| Q2 2019 Q2Q % growth | 74.706B | 57.195B | 17.511B | 30.62% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |